Chemical chaperones and permissive temperatures alter localization of Gaucher disease associated glucocerebrosidase variants - PubMed (original) (raw)
Comparative Study
. 2006 May 23;1(4):235-51.
doi: 10.1021/cb600187q.
Affiliations
- PMID: 17163678
- DOI: 10.1021/cb600187q
Comparative Study
Chemical chaperones and permissive temperatures alter localization of Gaucher disease associated glucocerebrosidase variants
Anu R Sawkar et al. ACS Chem Biol. 2006.
Abstract
Point mutations in the lysosomal hydrolase, glucocerebrosidase (GC), can cause Gaucher disease, a common lysosomal storage disease. Several clinically important GC mutations impede folding in the endoplasmic reticulum (ER) and target these enzymes for ER-associated degradation (ERAD). The removal of these misfolded proteins decreases the lysosomal concentration of GC, which results in glucosylceramide accumulation. The most common GC variant, N370S, and other clinically relevant variants, G202R and L444P, exhibit different cellular localization patterns in patient-derived fibroblasts. We show that these distributions can be altered by manipulation of the ER folding environment, either by chemical chaperones or by temperature shifts. N370S, L444P, and G202R GC are destabilized in the neutral pH environment of the ER, rendering them prone to ERAD. Fibroblasts harboring the G202R and L444P GC mutations grown at 30 degrees C localize the mutant proteins to the lysosome, and this increases total GC activity. Both of these temperature-sensitive mutants appear to be stable at 37 degrees C once they are trafficked to the low pH environment of the lysosome. Chemical chaperones correct the ER instability and significant ER retention of G202R GC. N370S is also destabilized under ER simulating conditions, a deficiency that is corrected by chemical chaperone binding. These data clearly show manipulating the ER environment with chemical chaperones increases the lysosomal concentration of partially active GC variants and suggest that small molecules could be used to treat Gaucher disease.
Comment in
- Reclamation of proteins from the cellular scrap heap.
Gestwicki JE. Gestwicki JE. ACS Chem Biol. 2006 May 23;1(4):201-3. doi: 10.1021/cb6001784. ACS Chem Biol. 2006. PMID: 17163671 Review.
Similar articles
- Impaired trafficking of mutants of lysosomal glucocerebrosidase in Gaucher's disease.
Schmitz M, Alfalah M, Aerts JM, Naim HY, Zimmer KP. Schmitz M, et al. Int J Biochem Cell Biol. 2005 Nov;37(11):2310-20. doi: 10.1016/j.biocel.2005.05.008. Int J Biochem Cell Biol. 2005. PMID: 15982918 - Gaucher disease-associated glucocerebrosidases show mutation-dependent chemical chaperoning profiles.
Sawkar AR, Adamski-Werner SL, Cheng WC, Wong CH, Beutler E, Zimmer KP, Kelly JW. Sawkar AR, et al. Chem Biol. 2005 Nov;12(11):1235-44. doi: 10.1016/j.chembiol.2005.09.007. Chem Biol. 2005. PMID: 16298303 - Ca2+ homeostasis modulation enhances the amenability of L444P glucosylcerebrosidase to proteostasis regulation in patient-derived fibroblasts.
Wang F, Agnello G, Sotolongo N, Segatori L. Wang F, et al. ACS Chem Biol. 2011 Feb 18;6(2):158-68. doi: 10.1021/cb100321m. Epub 2010 Nov 10. ACS Chem Biol. 2011. PMID: 21043486 - Gaucher disease.
Butters TD. Butters TD. Curr Opin Chem Biol. 2007 Aug;11(4):412-8. doi: 10.1016/j.cbpa.2007.05.035. Epub 2007 Jul 23. Curr Opin Chem Biol. 2007. PMID: 17644022 Review. - Gaucher disease among Chinese patients: review on genotype/phenotype correlation from 29 patients and identification of novel and rare alleles.
Choy FY, Zhang W, Shi HP, Zay A, Campbell T, Tang N, Ferreira P. Choy FY, et al. Blood Cells Mol Dis. 2007 May-Jun;38(3):287-93. doi: 10.1016/j.bcmd.2006.11.003. Epub 2006 Dec 29. Blood Cells Mol Dis. 2007. PMID: 17196853 Review.
Cited by
- The delicate balance between secreted protein folding and endoplasmic reticulum-associated degradation in human physiology.
Guerriero CJ, Brodsky JL. Guerriero CJ, et al. Physiol Rev. 2012 Apr;92(2):537-76. doi: 10.1152/physrev.00027.2011. Physiol Rev. 2012. PMID: 22535891 Free PMC article. Review. - Design and Synthesis of Potent Quinazolines as Selective β-Glucocerebrosidase Modulators.
Zheng J, Chen L, Schwake M, Silverman RB, Krainc D. Zheng J, et al. J Med Chem. 2016 Sep 22;59(18):8508-20. doi: 10.1021/acs.jmedchem.6b00930. Epub 2016 Sep 6. J Med Chem. 2016. PMID: 27598312 Free PMC article. - Chemical and biological approaches for adapting proteostasis to ameliorate protein misfolding and aggregation diseases: progress and prognosis.
Lindquist SL, Kelly JW. Lindquist SL, et al. Cold Spring Harb Perspect Biol. 2011 Dec 1;3(12):a004507. doi: 10.1101/cshperspect.a004507. Cold Spring Harb Perspect Biol. 2011. PMID: 21900404 Free PMC article. Review. - Detection of ligand binding hot spots on protein surfaces via fragment-based methods: application to DJ-1 and glucocerebrosidase.
Landon MR, Lieberman RL, Hoang QQ, Ju S, Caaveiro JM, Orwig SD, Kozakov D, Brenke R, Chuang GY, Beglov D, Vajda S, Petsko GA, Ringe D. Landon MR, et al. J Comput Aided Mol Des. 2009 Aug;23(8):491-500. doi: 10.1007/s10822-009-9283-2. Epub 2009 Jun 12. J Comput Aided Mol Des. 2009. PMID: 19521672 Free PMC article. - A New Glucocerebrosidase Chaperone Reduces α-Synuclein and Glycolipid Levels in iPSC-Derived Dopaminergic Neurons from Patients with Gaucher Disease and Parkinsonism.
Aflaki E, Borger DK, Moaven N, Stubblefield BK, Rogers SA, Patnaik S, Schoenen FJ, Westbroek W, Zheng W, Sullivan P, Fujiwara H, Sidhu R, Khaliq ZM, Lopez GJ, Goldstein DS, Ory DS, Marugan J, Sidransky E. Aflaki E, et al. J Neurosci. 2016 Jul 13;36(28):7441-52. doi: 10.1523/JNEUROSCI.0636-16.2016. J Neurosci. 2016. PMID: 27413154 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous